BACKGROUND: Sucrose is widely used to manage procedural pain in term newborns despite a lack of evidence of its effectiveness for different procedures and infant populations. Our objectives were to evaluate the effectiveness and safety of sucrose in newborns undergoing various medical procedures within 2 days of birth. METHODS: We performed a double-blind, randomized controlled trial. We included newborns (>or= 36 weeks gestation) of diabetic mothers and nondiabetic mothers. Each newborn received 2 mL of a 24%-sucrose or placebo solution before all procedures. We used the Premature Infant Pain Profile to assess pain during intramuscular injection of vitamin K, venipuncture for the newborn screening test and the first 3 heel lances for glucose monitoring (newborns of diabetic mothers only). Scores ranged from from 0 (no pain) to 18 (maximum pain). RESULTS: We included 240 newborns (120 from diabetic mothers, 120 from nondiabetic mothers). The overall mean pain score was lower among newborns who received sucrose than among those who received a placebo (mean difference -1.3, 95% confidence interval [CI] -2.0 to -0.6). We found that pain scores during intramuscular injection did not differ significantly between the sucrose and placebo groups for newborns of diabetic or nondiabetic mothers (newborns of nondiabetic mothers: mean difference -1.1, 95% CI -2.4 to 0.2; newborns of diabetic mothers: mean difference -1.0, 95% CI -2.4 to 0.4). During venipuncture, newborns who received sucrose had lower pain scores compared with those who received a placebo (newborns of nondiabetic mothers: mean difference -3.2, 95% CI -4.6 to -1.8; newborns of diabetic mothers: mean difference -2.4, 95% CI -3.8 to -1.0). Among newborns of diabetic mothers, there was no difference in pain during the first 3 heel lances or mean glucose levels between the sucrose and placebo groups (p = 0.94 and p = 0.29 respectively). INTERPRETATION: We found a modest reduction of pain in newborns of both diabetic and nondiabetic mothers when sucrose was used for all medical procedures performed in the first 2 days after birth. However, when each procedure was analyzed separately, we found that the effectiveness of sucrose was limited to venipuncture for the newborn screening test. (http://Clinicaltrials.gov trial register no. NCT00213213.).
RCT Entities:
BACKGROUND:Sucrose is widely used to manage procedural pain in term newborns despite a lack of evidence of its effectiveness for different procedures and infant populations. Our objectives were to evaluate the effectiveness and safety of sucrose in newborns undergoing various medical procedures within 2 days of birth. METHODS: We performed a double-blind, randomized controlled trial. We included newborns (>or= 36 weeks gestation) of diabetic mothers and nondiabetic mothers. Each newborn received 2 mL of a 24%-sucrose or placebo solution before all procedures. We used the Premature InfantPain Profile to assess pain during intramuscular injection of vitamin K, venipuncture for the newborn screening test and the first 3 heel lances for glucose monitoring (newborns of diabetic mothers only). Scores ranged from from 0 (no pain) to 18 (maximum pain). RESULTS: We included 240 newborns (120 from diabetic mothers, 120 from nondiabetic mothers). The overall mean pain score was lower among newborns who received sucrose than among those who received a placebo (mean difference -1.3, 95% confidence interval [CI] -2.0 to -0.6). We found that pain scores during intramuscular injection did not differ significantly between the sucrose and placebo groups for newborns of diabetic or nondiabetic mothers (newborns of nondiabetic mothers: mean difference -1.1, 95% CI -2.4 to 0.2; newborns of diabetic mothers: mean difference -1.0, 95% CI -2.4 to 0.4). During venipuncture, newborns who received sucrose had lower pain scores compared with those who received a placebo (newborns of nondiabetic mothers: mean difference -3.2, 95% CI -4.6 to -1.8; newborns of diabetic mothers: mean difference -2.4, 95% CI -3.8 to -1.0). Among newborns of diabetic mothers, there was no difference in pain during the first 3 heel lances or mean glucose levels between the sucrose and placebo groups (p = 0.94 and p = 0.29 respectively). INTERPRETATION: We found a modest reduction of pain in newborns of both diabetic and nondiabetic mothers when sucrose was used for all medical procedures performed in the first 2 days after birth. However, when each procedure was analyzed separately, we found that the effectiveness of sucrose was limited to venipuncture for the newborn screening test. (http://Clinicaltrials.gov trial register no. NCT00213213.).
Authors: K J S Anand; C Celeste Johnston; Tim F Oberlander; Anna Taddio; Victoria Tutag Lehr; Gary A Walco Journal: Clin Ther Date: 2005-06 Impact factor: 3.393
Authors: K J S Anand; Jacob V Aranda; Charles B Berde; Shaavhrée Buckman; Edmund V Capparelli; Waldemar A Carlo; Patricia Hummel; John Lantos; C Celeste Johnston; Victoria Tutag Lehr; Anne M Lynn; Lynne G Maxwell; Tim F Oberlander; Tonse N K Raju; Sulpicio G Soriano; Anna Taddio; Gary A Walco Journal: Clin Ther Date: 2005-06 Impact factor: 3.393
Authors: Kanwaljeet J S Anand; Jacob V Aranda; Charles B Berde; ShaAvhrée Buckman; Edmund V Capparelli; Waldemar Carlo; Patricia Hummel; C Celeste Johnston; John Lantos; Victoria Tutag-Lehr; Anne M Lynn; Lynne G Maxwell; Tim F Oberlander; Tonse N K Raju; Sulpicio G Soriano; Anna Taddio; Gary A Walco Journal: Pediatrics Date: 2006-03 Impact factor: 7.124
Authors: Daniella W E Roofthooft; Sinno H P Simons; Richard A van Lingen; Dick Tibboel; John N van den Anker; Irwin K H Reiss; Monique van Dijk Journal: Neonatology Date: 2017-05-31 Impact factor: 4.035
Authors: Fathia A Elserafy; Saad A Alsaedi; Julita Louwrens; Bakr Bin Sadiq; Ali Y Mersal Journal: Ann Saudi Med Date: 2009 May-Jun Impact factor: 1.526